NCT01874080View on ClinicalTrials.gov

Bioequivalence Study

PHASE1CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions

Diabetes

Interventions

DRUG

Saxagliptin/Metformin

Trial Locations (1)

78209

Icon Development Solutions, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY